CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 884 enrolled
Drug / intervention
ADRD-PC Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04948866
NCT04948866N/ACompleted

Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers

University of North Carolina, Chapel Hill·interventional·Posted Jul 2, 2021·Updated Dec 16, 2025

In Brief

A clinical study evaluating ADRD-PC Program for Dementia and 7 related conditions. Completed, enrolled 884 participants across 5 sites.

Detailed Summary

Millions of Americans have late-stage Alzheimer's and related dementias (ADRD), causing suffering due to loss of awareness of self and family, progressive dependency, physical and neuropsychiatric symptoms, and physical, emotional and financial strain for caregivers. Investigators now propose a multi-site randomized clinical trial of the ADRD Palliative Care (ADRD-PC) program for persons with late-stage ADRD and their family caregivers, triggered during hospitalization. Investigators aim to learn if this program of dementia-specific palliative care, standardized caregiver education, and transitional care is effective to reduce burdensome hospital transfers, improve symptom treatment and control, augment supportive services, and reduce nursing home transitions for patients, and to improve caregiver outcomes of communication, shared decision-making and distress.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 2, 2021
Enrollment StartJul 26, 2021
Primary CompletionFeb 1, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5 years ago

Interventions

ADRD-PC Programbehavioral

Included in arm/group descriptions